top of page
AI for Real Evidence and 
Real Impact in Oncology

Our Mission

Transform oncology with AI to fast-track life-saving treatments.

Inka Health is pioneering the use of advanced AI-driven analytics and real-world multimodal data to revolutionize clinical research and drug development.

 

We integrate cutting-edge technologies with rigorous methodologies to deliver actionable insights that drive innovation and precision in oncology.

 

Our commitment: empowering healthcare advancements with clarity and precision.

Inka Health Statistical Consulting Services

Leadership

paul arora 2_edited_edited.jpg

Paul Arora, PhD

Chief Executive Officer

Paul Arora is CEO of Inka Health and an Adjunct Professor at the University of Toronto. He is an expert in epidemiology, specializing in real-world evidence, health outcomes, and causal inference. He has led numerous large-scale consulting projects. He previously founded Lighthouse Outcomes (acquired).

LinkedIn
Google Scholar
Website Link
Alind Gupta New_edited_edited_edited.jpg

Alind Gupta, PhD

Chief Scientific Officer

Alind Gupta is CSO at Inka Health and an Adjunct Professor at the University of Toronto. He has deep technical expertise in advanced real-world evidence, AI and causal inference methods. He has led advanced analytics projects at a major US consultancy and is a globally referenced author in health technology assessment (HTA) guidance documents.

LinkedIn
Google Scholar
Website Link
github_edited.png
Winson Cheung Oncology Canada

Winson Cheung, MD

Medical Advisor

Winson Y. Cheung is a Full Professor at the University of Calgary and an expert in medical oncology and real-world evidence. With 15+ years in cancer research, he has published over 300 scientific papers and secured over $20M in research funding, specializing in health outcomes and real-world evidence generation in oncology.

LinkedIn
Google Scholar
Website Link
Steve Jones.png

Steven Jones, PhD

Scientific Advisor

Steven Jones is Head of Bioinformatics and Co-Director of the Genome Sciences Centre in Vancouver, and Distinguished Scientist at the BC Cancer Research Institute. He is among the world’s most highly cited researchers in his field, with pioneering contributions to bioinformatics and cancer genomics.

LinkedIn
Google Scholar
Website Link

Strategic Advisors

J Orbinski 2025_edited.jpg

James Orbinski, MD

James is a globally renowned humanitarian, scholar, and Officer of the Order of Canada. He is the Founding Director of York University's Dahdaleh Institute for Global Health Research and former International Council President of Médecins Sans Frontières (Doctors Without Borders), where he accepted the Nobel Peace Prize on behalf of the organization in 1999.

LinkedIn
Google Scholar
Website Link
ed mills_edited.jpg

Edward Mills, PhD

Ed Mills is the co-founder of MTEK Sciences and Redwood Outcomes, both successfully acquired by major industry players. He is a principal investigator of multiple adaptive platform trials and large-scale studies and has authored over 550 peer-reviewed papers in leading journals, including NEJM, The Lancet, and JAMA.

LinkedIn
Google Scholar
Website Link
kristian thorlund headshot_edited_edited

Kristian Thorlund, PhD

Kristian is the co-founder of Redwood Outcomes, MTEK Sciences (both acquired), and rAire, as well as the founder of Biospark.ai. A leading biostatistician specializing in Bayesian methods, he is a Clarivate Analytics Highly Cited Researcher, recognized for his impactful contributions to the field.

LinkedIn
Google Scholar
Website Link

Our Partners

LSO-Updated-Helix-Logo_2x_edited.png
Breast-Cancer-Canada-logo-Stacked-1C-Gre
GIPAM-removebg-preview_edited_edited.png
Oncology Outcomes_edited_edited.png
image371_edited_edited.png
University of Toronto 2_edited_edited.pn
Our Strengths
consulting relationships and support for analytics

Partnership

Enduring Relationships

Dedicated Partners

More than service providers, we commit to building long-term, sustainable relationships.
 

Customized Solutions

Tailoring our approach to meet the unique needs of each client.
 

Partner-Centric

Focused on delivering bespoke strategies that ensure collaborator satisfaction and success.

confidence in analytics and statistical methods

Confidence

Excellence in Methods

Superior Analytics

Instilling confidence with top-tier, transparent methods.
 

Evidence-Based

Leveraging ITC and real-world evidence for impactful insights.
 

Reliability & Impact

Ensuring our solutions are both dependable and effective.

Data agnostic independent service provider neutral

Data Agnosticism

Flexible Strategies

Versatility in Data

A specialized approach means we can work with diverse data sources, ranging from RCTs to industry access programs.

​

High Standards

Transparency and rigor in all analytics processes.
 

Effective Handling

Ensuring adept management of various data types for comprehensive insights. We welcome any and all data provided by collaborators.

innovative statistical analysis and study design

Innovation

Strategic Integration of AI

Innovative AI Use

Rooted in innovative, solution-oriented AI applications for analytics.
 

Focus on Causal Inference

Emphasizing the judicious use of AI to derive authentic insights from real-world data.
 

Distinctive Methods

Setting our approaches apart with advanced, credible analysis techniques.

Quality

Adherence to Best Practices

Strictly following the latest approaches in RWE and ITC, ensuring top-tier analytics quality.
 

Regulatory Alignment

In line with NICE, FDA, ISPOR, and CADTH guidelines for excellence in study design and reporting.
 

Quality Assurance

Commitment to the highest standards in all analytical processes.

Speed

Accelerated Analytics

Utilizing advanced automation for swift insights, delivering results in half the traditional time.
 

Investment in Innovation

Embracing automation and machine learning for efficient decision-making.
 

Impact on Healthcare

Ensuring timely decisions that significantly enhance patient outcomes.

Leadership

Thought Leadership

Boasting over 500 published scientific papers by our founding and advisory team.
 

Methodological Innovation

At the cutting edge with techniques like target trial emulation and Bayesian borrowing.
 

Accurate Insights

Providing reliable insights through advanced methodologies.

Collaborator Testimonials

"The team's profound understanding of intricacies surrounding real-world evidence and application of cutting-edge methodologies has greatly contributed to the field."

"Winson and team have always been my first port of call for invaluable guidance on implementing innovative methods to enhance the credibility and acceptance of real-world evidence (RWE). The team's profound understanding of the intricacies surrounding real-world evidence and application of cutting-edge methodologies has greatly contributed to the field, showing how RWE can meet the stringent standards set by HTA and payer stakeholders."

 

-  Global Head Real-World Evidence & Market Access at a large-cap pharmaceutical company

Scientific Advisors

Contact US

Toronto
Calgary Canada

Calgary

image_edited.png

Vancouver

© 2025 Inka Health. All Rights Reserved. Content on this website, including text, images, and logos, is the property of Inka Health and is protected by Canadian and international copyright laws. No part of this website may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Inka Health., except in the case of brief quotations embodied in critical reviews and certain other noncommercial uses permitted by copyright law. For permission requests, write to Inka Health., addressed “Attention: Permissions Coordinator,” at the Contact Form provided on this site.

  • X
  • LinkedIn
  • Youtube

© 2024 Inka Health

bottom of page